‪‎ChoiceBroking‬ ‪‎Financial‬ Tips Morning Tea ‪Buy‬ ‪‎AUROPHARMA‬ @822-827 ‪TGT‬ 844 ‪‎SL‬ 813 BUY ‪PIDILITE‬ @ 550-554 TGT 565 SL 544

1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Risedronate Sodium Tablets
USP, 5 mg, 30 mg and 35 mg (ANDA 200296). This approval is an extension of tentative approval received on 10th October 2012. This product is ready for
launch. The approved ANDA is bioequivalentand therapeutically equivalentto thereference listed drugproduct (RLD) ACTONELTablets of Warner Chilcott
Co., LLC RisedronateSodium Tablets areusedin thetreatmentof Osteoporosis.Theapprovedproducthasanestimatedmarketsizeof$113 millionforthe
twelvemonths endingOctober2015. Thecompanynowhasatotalof219 ANDAapprovals(191 Finalapprovalsincluding10 from AurolifePharmaLLCand
28Tentativeapprovals)fromUSFDA.
Technical Outlook : The stock has been trading with the support of its rising trend line at 810.50 levels on hourly chart. Moreover, stock has been trading
above 21EMA, which indicates thatshort term trend is up. Stock has formed bullish candle stick with good volume activity. A momentum indicator RSI has
moved above 40 levels on daily chart, which pointout for positivebreath in the stock. So for trading perspective one could Buy in the range of 822-827 for
theTargetof844withtheSLof813.
AUROPHARMA
PIDILITE
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
02nd Dec 2015
Buy in the range of 550-554 for the Target of 565 with the SL of 544
Buy in the range of 822-827 for the Target of 844 with the SL of 813
Adhesives and industrial chemicals maker Pidilite Industries' step down subsidiary -- Pidilite Lanka (PLPL) -- has acquired Chemifix trademark and other
brands associated with PVAC adhesives business from Sri Lanka-based CIC Holdings Plc. PLPL has also acquired the commercial and technical knowhow
relating toPVAC Adhesivebusinessfrom CIC Holdings.PidiliteInternationalandPidiliteMiddleEast,whollyowned subsidiaries of theCompanyhold76%of
the paid up capital in PLPL. CIC Holdings PLC is a large conglomerate in Sri Lanka and is involved in number of segments in Sri Lanka such as chemicals,
fertilizers,pharmaceuticals,agrichemical,foodproductsetc.
TechnicalOutlook:Onhourlychart,stockhasgivenbreakoutofitsfallingtrendlineat551levels.Moreover,stockhasbeentradingabove21EMAonhourly
chart, which indicates that short term trend remains up. A momentum indicator RSI reading is above 60 marks with positive crossover which point out for
positivebreathinthestock.SofortradingperspectiveonecouldBuyintherangeof550-554 fortheTargetof565withtheSLof544.
US stocks started December stronger on Tuesday as health and consumer shares bounced back while auto sales suggested upbeat growth in November.
The S&P health care index jumped 1.7 percent, while the consumer discretionary index was up 1 percent, both retracing Monday's losses. UnitedHealth
Group Inc's shares rose 3.1 percent to USD 116.26 after its chief executive defended the company's possible withdrawal from the Obamacare health
insuranceexchanges.SharesofAnthemwereup4.2percentatUSD135.82.StrongUSautosalesinNovemberkepttheindustryonpaceforarecordyearin
2015.SharesofFordwereup1.6percentatUSD14.56,thoughGeneralMotors'shareswereup0.2percentatUSD36.26.TheDowJonesindustrialaverage
rose 168.43 points, or 0.95 percent, to 17,888.35, the S&P 500 gained 22.22 points, or 1.07 percent, to 2,102.63 and the Nasdaq Composite added 47.64
points,or0.93percent,to5,156.31.
Asian stocks stuttered in early trade on Wednesday after downbeat US manufacturing data raised concerns about the health of the world's biggest
economy, while the dollar retreated from 8-1/2-month highs. Japan's Nikkei dipped 0.2 percent, Australian stocks lost 0.5 percent and South Korea's Kospi
shed 0.3 percent. MSCI's broadest index of Asia-Pacific shares outside Japan stood flat. Data released Tuesday showed the US manufacturing sector
contractedlastmonthtoitsweakestlevelsinceJune2009,whileconstructionspendingroseinOctobertothehighestlevelsinceDecember2007.Themixed
data prompted markets to question whether the US economy was ready for an interest rate hike that could come as early as this month. Shanghai
Composite index traded at 0.19 to 3462.85, Hang Seng index traded at 0.10 % to 22404.70, Japan's benchmark Nikkei 225 index traded at -0.05% to
20002.12,SouthKorea'sKospiindextradedupby-0.36%to2016.67levels.TheSGXNiftysuggestsaflattopositiveopeningforourmarketsasitistradingat
7997,upby12points.

2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
Result Calendar:
02nd Dec 2015
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 1/12/2015 534060 PMCFIN SEABIRD DISTRIBUTORS PRIVATE LIMITED S 3500000 0.75
2 1/12/2015 534060 PMCFIN PARESH RAMJIBHAI CHAUHAN S 3302969 0.77
3 1/12/2015 534060 PMCFIN PARESH RAMJIBHAI CHAUHAN B 3302969 0.76
4 1/12/2015 523277 GVFILM GANESHMAL SHYAMSUNDER (HUF) B 2532430 0.75
5 1/12/2015 523277 GVFILM GOPAL DAS SONKIA S 2532430 0.75
6 1/12/2015 530655 GOODLUC VENUS INSEC PRIVATE LIMITED S 1000000 92.92
7 1/12/2015 531731 AARYAGLOBL AROHA CHEMTRADING LLP S 747276 1.73
8 1/12/2015 531977 CHLOGIST AARTIE SUNIL ANANDPARA B 717073 15
9 1/12/2015 533268 SEATV SUMTINATH SHARES AND SERVICES PRIVA B 519500 11.07
10 1/12/2015 531855 PRABHAVIN PARKWAY PROPERTIES PRIVATE LIMITED B 245000 1.74

3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
02nd Dec 2015
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Kunal Parmar
Digitally signed by Kunal Parmar
DN: cn=Kunal Parmar, o=Choice Equity Broking
Pvt Ltd., ou=Research Dept,
email=kunal.parmar@choiceindia.com, c=IN
Date: 2015.12.02 08:54:59 +05'30'